Zee5 Telugu: ఈ జులైలో జీ5 తెలుగుతో ఫుల్ జోష్.. వచ్చిన, వస్తున్న సినిమాలు, వెబ్ సిరీస్ లిస్ట్ అనౌన్స్ చేసిన ఓటీటీ

భారతదేశం, జూలై 4 -- Zee5 Telugu: జీ5 తెలుగు ప్లాట్‌ఫామ్ జులై నెలలో ఓటీటీ ఆడియన్స్‌కు అదిరిపోయే బ్లాక్‌బస్టర్ విందును వడ్డించబోతోంది. బ్యాక్ టు బ్యాక్ ఎంటర్‌టైన్‌మెంట్‌తో డిజిటల్ స్క్రీన్స్‌ను షేక్ చేయ... Read More

Trump Accounts Launch as Six Million Families Enroll in US Children's Savings Program

WASHINGTON, July 4 -- For every American child born in the last eighteen months, the federal government now holds a $1,000 stake in their financial future. What the markets do with it over the next tw... Read More

NYT Mini Crossword Hints and Answers - July 4, 2026

New Delhi, July 4 -- All 13 answers to today's NYT Mini Crossword (Saturday, July 4, 2026) are listed below. The three entries most likely to cause trouble on this Saturday grid are ARIZONA (4-Across)... Read More

Securing India's livestock feed supply chain in a changing climate

New Delhi, July 4 -- India's southwest monsoon has once again exposed the vulnerability of the country's livestock feed ecosystem. The India Meteorological Department (IMD) has revised its 2026 foreca... Read More

Singapore Clinical Trial: A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Study to Evaluate the Gastric Emptying Delay, Pharmacokinetics, Safety, and Tolerability of Eloralintide in Participants with Obesity or Overweight

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Investigator- and Participant-Blinded, Placebo-Controlled, Randomized, Multiple-Dose Stu... Read More

Singapore Clinical Trial: A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating the safety and tolerability of ARD001 in healthy adult subjects and a Phase 2 open-label, multiple-dose study in adult subjects with hemophilia A

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 randomized, double-blind, placebo-controlled, single-ascending-dose study investigating t... Read More

Singapore Clinical Trial: A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Placebo-Controlled Phase 3 Followed by an Open-Label Extension to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of Radiprodil in Participants With GRIN-Related Neurodevelopmental Disorder

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter Study With an Open-Label Phase 1b and a Randomized, Double-Blind, Plac... Read More

Singapore Clinical Trial: A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Solution for Injection (TLX101-Tx) Plus Lomustine Versus Lomustine Alone in Patients with Radiographically Confirmed Recurrent Glioblastoma at First Recurrence (IPAX-3)

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicenter, Prospective, Controlled, Open-Label Pivotal Study of Iodofalan (131I) Soluti... Read More

Singapore Clinical Trial: RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Monotherapy or Daraxonrasib Plus Gemcitabine and Nab-paclitaxel versus Gemcitabine and Nab-paclitaxel as a First-Line Treatment for Patients with Metastatic Pancreatic Adenocarcinoma

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib Mo... Read More

Singapore Clinical Trial: A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembrolizumab in Participants with Advanced Solid Tumors, including Participants with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) Tumors

Singapore, July 4 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembro... Read More

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»